Malegra 100 mg tablets and similar products:  Not “FDA Approved” Malegra 100 mg itself — as a brand — is not approved by the U.S. Food and Drug Administration (FDA). It is a generic sildenafil product made in India and not listed as an FDA‑approved marketed drug in the United States. The FDA approves specific drug products and brands that have met its safety, effectiveness, and manufacturing quality standards for sale in the U.S. Generic versions of a drug can be FDA‑approved if they meet those standards and are registered in the FDA’s database, but that approval is for the specific manufacturer and product, not Malegra 100 Mg all generics with the same name.  2. Active Ingredient (Sildenafil) Has FDA‑Approved Versions The active ingredient — sildenafil citrate — is an FDA‑approved medication for erectile dysfunction (under brand names like Viagra and generic versions) in the U.S. However, being an FDA‑approved active ingredient doesn’t automatically mean every generic brand worldwide (like Malegra) is FDA‑approved.   In India, Medicines Are Regulated by the CDSCO In India, the regulator equivalent to the U.S. FDA is the Central Drugs Standard Control Organisation (CDSCO), headed by the Drug Controller General of India (DCGI). It oversees approval, registration, and quality of pharmaceutical products in the Indian market. Malegra 100 mg and other generic sildenafil tablets are typically registered with the Indian regulator and available in the Indian market through licensed manufacturers and pharmacies. But this is a CDSCO/DCGI approval, not a U.S. FDA product approval.